5,6-dihydroxy-NADP

5,6-dihydroxy-NADP Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name 5,6-dihydroxy-NADP
Generic 5,6-dihydroxy-NADP
Type
Formula C21H32N7O19P3
Weight Average: 779.4356
Monoisotopic: 779.096581413
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
5,6-dihydroxy-NADP
5,6-dihydroxy-NADP

Innovators Monograph

You find simplified version here 5,6-dihydroxy-NADP



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447659
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506343
https://www.chemspider.com/Chemical-Structure.394690.html
https://zinc.docking.org/substances/ZINC000098209251
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NZQ
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol
Heparin Disaccharide I-S
EM-1745
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
1-Hydroxyamine-2-Isobutylmalonic Acid
Triethylene glycol
2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid
(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid
Flavin-N7 protonated-adenine dinucleotide
Deoxyuridine-5'-Triphosphate
Shoulder CT scan
CPK isoenzymes test
Temperature measurement
Nasal mucosal biopsy
Creatinine Test
Bilirubin in Urine
Cystoscopy
Drug Testing
Left heart catheterization
Abnormal hemoglobins testing
Previously treated with an HCV regimen containing an NS5A inhibitor Chronic hepatitis C genotype 5
Pituitary-dependent Cushing's syndrome
Respiratory Symptoms caused by Cystic fibrosis
Juvenile-onset Hypophosphatasia
Moderate Nosocomial pneumonia
Moderate Community acquired pneumonia
Superficial Conjunctival injuries
Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Pancreatic Insufficiency
Type I Plasminogen Deficiency.